CliffBio
small molecule

BELBUCA

BUPRENORPHINE HYDROCHLORIDE

Loss of exclusivityDecember 2032latest FDA-listed patent expiry
CompanyBioDelivery Sciences International →See this company's full patent-cliff portfolio

Drug detail

Brand nameBELBUCA
Active ingredientBUPRENORPHINE HYDROCHLORIDE
StrengthEQ 0.9MG BASE
Dosage formFILM
RouteBUCCAL
ModalitySmall molecule
FDA approvalOctober 2015
Marketing statusRX

Listed patents

PatentExpiresType
9901539December 2032use U-1556
8147866July 2027product
9655843July 2027product

More from BioDelivery Sciences International

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

BELBUCA patent cliff — loss of exclusivity December 2032 | CliffBio